| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Power Teams and Information Collection |
|
Digg It - Power Teams and Information Collection
Power Teams work well when there is an element of trust and integrity. Holdi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ng the information for a project is certainly one of those areas where trust ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in is prominent. No one should own the information but all need to have unlimit lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ed access to it. Even then, the information needs to be stored and there sho here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ld be only one or two administrators that look after it. This may seem like d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro a lot of work but the ownership issue can cause problems unless defined ahea ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc of time. If the information is stored in a database, you may want only one easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi or two people to do updates or additions and deletions. If you add too many nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically eople to the administration of the data, there can be duplication of effort and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ and even worse, deletion of data that is crucial to the success of your proj ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ct.
Information ownership should not be a matter of territory. It ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a should, however, be a matter of control. One person on the project needs to dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod be responsible. This does not mean that others will not have access; it simp cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin y means that they will have limited abilities to manipulate the data. In oth tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen er words, they may only be allowed to read the information, add to it or mak t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel changes. They will not be allowed to delete anything, only the administrato ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust r should be allowed to do that.
Most projects have data, reports y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nd other things that must be prepared for the company buying the services. I . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de f you are working with a Power Team, put together a plan of responsibilities elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip before proceeding. This plan should also include who is responsible for what tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Avoid e-mail Overload and Still Keep Everyone Informed There Are A Lot of Hats in the Small Business and They All Fit Your Head Denver Airport Shuttle Options
|